Navidea Biopharmaceuticals, Inc.
(NYSE Amex Equities : NAVB)

( )
NAVB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.41%558.281.0%$831.35m
MDTMedtronic Plc -0.23%76.900.6%$662.06m
DHRDanaher Corp. 0.98%267.950.7%$632.68m
ABTAbbott Laboratories 0.89%104.780.8%$525.73m
ABMDABIOMED, Inc. -0.04%377.793.3%$521.45m
ISRGIntuitive Surgical, Inc. 0.62%267.960.8%$490.52m
BDXBecton, Dickinson & Co. 0.86%246.481.0%$430.02m
EWEdwards Lifesciences Corp. 0.44%72.590.4%$405.39m
SYKStryker Corp. 2.77%242.071.3%$316.75m
DXCMDexCom, Inc. 0.92%117.911.9%$289.68m
BAXBaxter International, Inc. 1.65%52.361.8%$270.40m
BSXBoston Scientific Corp. 1.04%45.631.0%$252.86m
AAgilent Technologies, Inc. 1.59%153.751.7%$218.07m
WSTWest Pharmaceutical Services, Inc. 0.40%235.921.6%$184.74m
ALGNAlign Technology, Inc. 0.69%187.336.4%$176.48m

Company Profile

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.